Related Experiment Videos
The new WHO nomenclature: lymphoid neoplasms
Susan J Leclair1, Bernadette F Rodak
1Department of Medical Laboratory Science at University of Massachusetts Dartmouth, Dartmouth, MA 02747-2300, USA. SLeclair@UMassD.edu
Summary
The World Health Organization (WHO) classification of lymphoid neoplasms showcases global collaboration. Regular updates by hematopathology societies advance understanding and treatment of blood cancers.
Area of Science:
- Hematopathology
- Oncology
- Medical Classification Systems
Background:
- The World Health Organization (WHO) classification system is crucial for standardizing the diagnosis of lymphoid neoplasms.
- Effective communication between pathologists and oncologists is vital for refining diagnostic criteria.
Purpose of the Study:
- To highlight the collaborative development of the WHO classification of lymphoid neoplasms.
- To emphasize the role of joint committees in advancing hematologic malignancy understanding.
Main Methods:
- International collaboration among pathologists and oncologists.
- Periodic review and updates by major hematopathology societies.
Main Results:
- The WHO classification serves as a model for global scientific cooperation.
- Ongoing updates ensure the classification reflects the latest scientific knowledge.
Conclusions:
- The collaborative nature of the WHO classification drives progress in diagnosing and treating lymphoid neoplasms.
- Continued international cooperation is essential for future advancements in hematologic oncology.